
Sign up to save your podcasts
Or
Plus ~ What to know about the substance the FDA calls "the Next Wave of the Opioid Epidemic".
What does the FDA actually do — and why does it matter to you? From regulating everything from mammograms to microwaves to navigating hot-button issues like autism treatments, Tylenol safety, and hormone replacement therapy, the FDA touches nearly every aspect of American life.
In this SmartHER News interview, FDA Commissioner Dr. Marty Makary sits down with Jenna to discuss public trust in medicine, new research on autism, the debate over acetaminophen use during pregnancy, and changing perspectives on women’s health and hormone therapy. Dr. Makary also opens up about his path from surgeon to policymaker, the challenges of modernizing the agency, and what he believes is at stake for America’s children and families.
👉 Whether you’re a parent, a patient, or just someone curious about how decisions get made in Washington, this conversation offers rare, direct insight into the FDA’s priorities — and the questions still being debated.
4.9
617617 ratings
Plus ~ What to know about the substance the FDA calls "the Next Wave of the Opioid Epidemic".
What does the FDA actually do — and why does it matter to you? From regulating everything from mammograms to microwaves to navigating hot-button issues like autism treatments, Tylenol safety, and hormone replacement therapy, the FDA touches nearly every aspect of American life.
In this SmartHER News interview, FDA Commissioner Dr. Marty Makary sits down with Jenna to discuss public trust in medicine, new research on autism, the debate over acetaminophen use during pregnancy, and changing perspectives on women’s health and hormone therapy. Dr. Makary also opens up about his path from surgeon to policymaker, the challenges of modernizing the agency, and what he believes is at stake for America’s children and families.
👉 Whether you’re a parent, a patient, or just someone curious about how decisions get made in Washington, this conversation offers rare, direct insight into the FDA’s priorities — and the questions still being debated.
2,438 Listeners
7,091 Listeners
2,332 Listeners
3,360 Listeners
10,420 Listeners
2,984 Listeners
2,895 Listeners
20,903 Listeners
1,842 Listeners
837 Listeners
510 Listeners
35,784 Listeners
2,101 Listeners
6,578 Listeners
3,644 Listeners